$6.00
-0.20-3.23%
At close: Dec 16, 4:00 PM EST
$6.01
0.010.17%
After Hours: 6:12 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Ardelyx Insider Trading Activity | NASDAQ:ARDX | Benzinga
Track the latest Ardelyx insider trading activity. Stay informed on recent buys, sells, and market impact for Ardelyx stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Ardelyx Inc Insiders Doing?
At Ardelyx Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 81.77K shares worth $452.74K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On November 25, 2025, Mike Kelliher, the company's SEE REMARKS sold 5.56K shares for $5.54 each.
- On November 25, 2025, Eric D. Foster, the company's CHIEF COMMERCIAL OFFICER sold 5.81K shares for $5.54 each.
- On November 25, 2025, Elizabeth Grammer, the company's SEE REMARKS sold 6K shares for $5.54 each.
Ownership Statistics for Ardelyx Inc
Shares Outstanding
242.974M
Insider Shares Owned
10.903M
Insider Percentage Owned
4.49%
Institutional Shares Held
84.800M
Institutional Percentage Held
34.9%
| Nov 25, 2025 | Elizabeth Grammer | SEE REMARKS | -6.00K | $5.54 | -$33.19K | SELL | -1.96% | 299.89K | Nov 21 | View |
| Nov 25, 2025 | Michael Raab | PRESIDENT & CEO | -46.89K | $5.54 | -$259.61K | SELL | -3.12% | 1.46M | Nov 21 | View |
| Nov 25, 2025 | Mike Kelliher | SEE REMARKS | -5.56K | $5.54 | -$30.79K | SELL | -2.01% | 271.18K | Nov 21 | View |
| Nov 25, 2025 | Laura A Williams | CHIEF PATIENT OFFICER | -6.43K | $5.54 | -$35.58K | SELL | -1.75% | 359.90K | Nov 21 | View |
| Nov 25, 2025 | Eric D. Foster | CHIEF COMMERCIAL OFFICER | -5.81K | $5.54 | -$32.19K | SELL | -1.93% | 295.68K | Nov 21 | View |
| Nov 25, 2025 | Joseph J. Reilly | SEE REMARKS | -11.09K | $5.54 | -$61.38K | SELL | -9.24% | 108.91K | Nov 21 | View |
| Aug 28, 2025 | Laura A Williams | CHIEF PATIENT OFFICER | -30.00K | $3.56 | -$440.18K | SELL | -7.57% | 366.32K | Aug 26 | View |
| Aug 28, 2025 | Mike Kelliher | CHIEF BUSINESS OFFICER | -5.42K | $5.93 | -$32.13K | SELL | -1.92% | 276.74K | Aug 21 | View |
| Aug 25, 2025 | Laura A Williams | CHIEF PATIENT OFFICER | -6.26K | $5.93 | -$37.14K | SELL | -1.56% | 396.32K | Aug 21 | View |
| Aug 25, 2025 | Justin Renz | CHIEF FINANCIAL OFFICER | -7.04K | $5.93 | -$41.74K | SELL | -1.69% | 409.05K | Aug 21 | View |
| Aug 25, 2025 | Michael Raab | PRESIDENT & CEO | -45.69K | $5.93 | -$271.00K | SELL | -2.95% | 1.50M | Aug 21 | View |
| Aug 25, 2025 | Elizabeth Grammer | SEE REMARKS | -5.84K | $5.93 | -$34.65K | SELL | -1.87% | 305.89K | Aug 21 | View |
| Aug 25, 2025 | Eric D. Foster | CHIEF COMMERCIAL OFFICER | -15.31K | $5.93 | -$90.80K | SELL | -4.83% | 301.50K | Aug 21 | View |
| Jun 18, 2025 | David Mott | DIRECTOR | 200.00K | $3.63 | $725.88K | BUY | 7.42% | 2.90M | Jun 16 | View |
| Jun 11, 2025 | David Mott | DIRECTOR | 200.00K | $3.69 | $737.26K | BUY | 8.01% | 2.70M | Jun 09 | View |
| May 22, 2025 | Laura A Williams | CHIEF MEDICAL OFFICER | -6.42K | $4.08 | -$26.21K | SELL | -1.57% | 402.58K | May 20 | View |
| May 22, 2025 | Justin Renz | CHIEF FINANCIAL OFFICER | -7.22K | $4.08 | -$29.46K | SELL | -1.71% | 416.09K | May 20 | View |
| May 22, 2025 | Michael Raab | PRESIDENT & CEO | -46.82K | $4.08 | -$191.08K | SELL | -2.93% | 1.55M | May 20 | View |
| May 22, 2025 | Mike Kelliher | SEE REMARKS | -14.52K | $4.08 | -$59.27K | SELL | -4.89% | 282.16K | May 20 | View |
| May 22, 2025 | Elizabeth Grammer | SEE REMARKS | -5.99K | $4.08 | -$24.46K | SELL | -1.89% | 311.73K | May 20 | View |
| May 22, 2025 | Eric D. Foster | CHIEF COMMERCIAL OFFICER | -2.51K | $4.08 | -$10.23K | SELL | -0.79% | 316.81K | May 20 | View |
| May 19, 2025 | David Mott | DIRECTOR | 100.00K | $3.29 | $329.12K | BUY | 4.17% | 2.50M | May 15 | View |
| May 05, 2025 | David Mott | DIRECTOR | 381.38K | $4.22 | $1.61M | BUY | 18.92% | 2.40M | May 02 | View |
| May 05, 2025 | Michael Raab | PRESIDENT & CEO | -20.83K | $2.62 | -$156.54K | SELL | -1.29% | 1.60M | May 02 | View |
| Apr 08, 2025 | Michael Raab | PRESIDENT & CEO | -20.83K | $2.79 | -$170.53K | SELL | -1.27% | 1.62M | Apr 04 | View |
| Mar 07, 2025 | Michael Raab | PRESIDENT & CEO | -20.83K | $3.17 | -$202.57K | SELL | -1.26% | 1.64M | Mar 07 | View |
| Feb 26, 2025 | David Mott | DIRECTOR | 77.73K | $5.00 | $388.74K | BUY | 4.01% | 2.02M | Feb 24 | View |
| Feb 21, 2025 | Laura A Williams | CHIEF MEDICAL OFFICER | -4.94K | $5.62 | -$27.78K | SELL | -1.60% | 303.80K | Feb 20 | View |
| Feb 21, 2025 | Justin Renz | CHIEF FINANCIAL OFFICER | -5.17K | $5.62 | -$29.08K | SELL | -1.78% | 285.97K | Feb 20 | View |
| Feb 21, 2025 | Michael Raab | PRESIDENT & CEO | -22.96K | $5.62 | -$129.12K | SELL | -2.07% | 1.09M | Feb 20 | View |
| Feb 21, 2025 | Elizabeth Grammer | SEE REMARKS | -4.29K | $5.62 | -$24.13K | SELL | -2.32% | 181.04K | Feb 20 | View |
| Jan 31, 2025 | Michael Raab | PRESIDENT & CEO | -20.83K | $3.18 | -$202.73K | SELL | -1.84% | 1.11M | Jan 31 | View |
| Jan 22, 2025 | David Mott | DIRECTOR | 199.00K | $4.99 | $992.67K | BUY | 11.44% | 1.94M | Jan 21 | View |
| Jan 10, 2025 | Michael Raab | PRESIDENT & CEO | -20.83K | $3.15 | -$200.68K | SELL | -1.81% | 1.13M | Jan 07 | View |
| Dec 23, 2024 | David Mott | DIRECTOR | 213.30K | $4.67 | $996.58K | BUY | 14.96% | 1.64M | Dec 19 | View |
| Dec 12, 2024 | Michael Raab | PRESIDENT & CEO | 0.00 | $3.13 | -$106.87K | SELL-OPTIONS | 0.00% | 1.15M | Dec 10 | View |
| Nov 27, 2024 | Michael Raab | PRESIDENT & CEO | -25.00K | $5.38 | -$134.48K | SELL | -2.13% | 1.15M | Nov 25 | View |
| Nov 22, 2024 | Laura A Williams | CHIEF MEDICAL OFFICER | -7.37K | $4.79 | -$35.32K | SELL | -2.33% | 308.75K | Nov 20 | View |
| Nov 22, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -7.18K | $4.79 | -$34.44K | SELL | -3.04% | 228.97K | Nov 20 | View |
| Nov 22, 2024 | Justin Renz | CHIEF FINANCIAL OFFICER | -5.26K | $4.79 | -$25.22K | SELL | -1.77% | 291.14K | Nov 20 | View |
| Nov 22, 2024 | Michael Raab | PRESIDENT & CEO | -31.98K | $4.79 | -$153.33K | SELL | -2.65% | 1.18M | Nov 20 | View |
| Nov 22, 2024 | Elizabeth Grammer | SEE REMARKS | -7.05K | $4.79 | -$33.78K | SELL | -3.66% | 185.33K | Nov 20 | View |
| Nov 22, 2024 | Robert Blanks | SEE REMARKS | -4.94K | $4.79 | -$23.69K | SELL | -1.55% | 314.42K | Nov 20 | View |
| Nov 14, 2024 | David Mott | DIRECTOR | 215.87K | $4.62 | $996.60K | BUY | 17.85% | 1.43M | Nov 13 | View |
| Nov 12, 2024 | Michael Raab | PRESIDENT & CEO | -2.74K | $4.90 | -$13.44K | SELL | -0.23% | 1.21M | Nov 11 | View |
| Nov 08, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | 0.00 | $4.21 | -$102.71K | SELL-OPTIONS | 0.00% | 231.21K | Nov 06 | View |
| Nov 06, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | 0.00 | $4.13 | -$98.63K | SELL-OPTIONS | 0.00% | 231.21K | Nov 04 | View |
| Oct 31, 2024 | Michael Raab | PRESIDENT & CEO | 0.00 | $3.45 | -$122.99K | SELL-OPTIONS | 0.00% | 1.21M | Oct 28 | View |
| Oct 15, 2024 | Michael Raab | PRESIDENT & CEO | -7.50K | $6.01 | -$45.08K | SELL | -0.62% | 1.21M | Oct 11 | View |
| Oct 01, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -49.56K | $6.92 | -$342.98K | SELL | -11.55% | 379.54K | Sep 27 | View |
| Sep 27, 2024 | Michael Raab | PRESIDENT & CEO | -3.00K | $6.07 | -$18.21K | SELL | -0.25% | 1.22M | Sep 26 | View |
| Sep 16, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -5.31K | $6.26 | -$33.25K | SELL | -1.04% | 505.13K | Sep 13 | View |
| Sep 13, 2024 | Michael Raab | PRESIDENT & CEO | 0.00 | $3.30 | -$161.75K | SELL-OPTIONS | 0.00% | 1.22M | Sep 11 | View |
| Aug 28, 2024 | Michael Raab | PRESIDENT & CEO | -7.50K | $6.22 | -$46.63K | SELL | -0.61% | 1.22M | Aug 27 | View |
| Aug 22, 2024 | Laura A Williams | CHIEF MEDICAL OFFICER | -7.41K | $5.86 | -$43.44K | SELL | -2.30% | 314.74K | Aug 20 | View |
| Aug 22, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -7.22K | $5.86 | -$42.31K | SELL | -2.99% | 233.84K | Aug 20 | View |
| Aug 22, 2024 | Justin Renz | CHIEF FINANCIAL OFFICER | -5.29K | $5.86 | -$31.00K | SELL | -1.76% | 295.26K | Aug 20 | View |
| Aug 22, 2024 | Michael Raab | PRESIDENT & CEO | -32.23K | $5.86 | -$188.85K | SELL | -2.56% | 1.23M | Aug 20 | View |
| Aug 22, 2024 | Elizabeth Grammer | SEE REMARKS | -7.09K | $5.86 | -$41.54K | SELL | -3.55% | 192.38K | Aug 20 | View |
| Aug 22, 2024 | Robert Ora Felsch | SEE REMARKS | -3.57K | $5.86 | -$20.90K | SELL | -3.75% | 91.56K | Aug 20 | View |
| Aug 22, 2024 | Robert Blanks | SEE REMARKS | -4.97K | $5.86 | -$29.12K | SELL | -1.53% | 319.36K | Aug 20 | View |
| Aug 20, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -20.00K | $3.48 | -$221.48K | SELL | -7.81% | 236.09K | Aug 16 - Aug 20 | View |
| Aug 14, 2024 | Michael Raab | PRESIDENT & CEO | -1.23K | $5.71 | -$7.02K | SELL | -0.10% | 1.26M | Aug 12 | View |
| Jul 31, 2024 | Michael Raab | PRESIDENT & CEO | 0.00 | $3.32 | -$139.61K | SELL-OPTIONS | 0.00% | 1.26M | Jul 29 | View |
| Jul 17, 2024 | Michael Raab | PRESIDENT & CEO | -7.50K | $5.97 | -$44.77K | SELL | -0.59% | 1.26M | Jul 15 | View |
| Jun 28, 2024 | Michael Raab | PRESIDENT & CEO | -2.31K | $6.59 | -$15.22K | SELL | -0.18% | 1.27M | Jun 28 | View |
| Jun 25, 2024 | Robert Blanks | SEE REMARKS | -38.00K | $5.96 | -$226.29K | SELL | -10.49% | 324.33K | Jun 21 | View |
| Jun 17, 2024 | Michael Raab | PRESIDENT & CEO | 0.00 | $3.82 | -$198.09K | SELL-OPTIONS | 0.00% | 1.27M | Jun 13 | View |
| Jun 07, 2024 | Laura A Williams | CHIEF MEDICAL OFFICER | -45.00K | $4.94 | -$758.08K | SELL | -12.26% | 322.15K | Jun 05 | View |
| Jun 05, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -17.87K | $7.00 | -$125.10K | SELL | -3.23% | 534.98K | Jun 03 | View |
| May 31, 2024 | Michael Raab | PRESIDENT & CEO | -7.50K | $6.72 | -$50.39K | SELL | -0.59% | 1.27M | May 29 | View |
| May 23, 2024 | Laura A Williams | CHIEF MEDICAL OFFICER | -4.79K | $7.81 | -$37.45K | SELL | -1.29% | 367.15K | May 21 | View |
| May 23, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -7.05K | $7.81 | -$55.09K | SELL | -2.70% | 253.97K | May 21 | View |
| May 23, 2024 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -6.70K | $7.81 | -$52.36K | SELL | -1.47% | 449.09K | May 21 | View |
| May 23, 2024 | Justin Renz | CHIEF FINANCIAL OFFICER | -5.17K | $7.81 | -$40.36K | SELL | -1.69% | 300.55K | May 21 | View |
| May 23, 2024 | Michael Raab | PRESIDENT & CEO | -31.48K | $7.81 | -$245.92K | SELL | -2.40% | 1.28M | May 21 | View |
| May 23, 2024 | Elizabeth Grammer | SEE REMARKS | -6.93K | $7.81 | -$54.11K | SELL | -3.36% | 199.47K | May 21 | View |
| May 23, 2024 | Robert Ora Felsch | SEE REMARKS | -3.48K | $7.81 | -$27.22K | SELL | -3.53% | 95.13K | May 21 | View |
| May 23, 2024 | Robert Blanks | SEE REMARKS | -4.86K | $7.81 | -$37.92K | SELL | -1.32% | 362.33K | May 21 | View |
| May 15, 2024 | Michael Raab | PRESIDENT & CEO | -3.00K | $7.99 | -$23.97K | SELL | -0.23% | 1.31M | May 14 | View |
| May 09, 2024 | Robert Ora Felsch | SEE REMARKS | -88.89K | $5.14 | -$1.66M | SELL | -48.09% | 95.95K | May 06 | View |
| May 09, 2024 | Elizabeth Grammer | SEE REMARKS | -64.23K | $5.37 | -$2.11M | SELL | -23.97% | 203.76K | May 06 | View |
| May 07, 2024 | Elizabeth Grammer | SEE REMARKS | -45.00K | $9.00 | -$405.00K | SELL | -14.38% | 267.99K | May 03 | View |
| May 07, 2024 | Laura A Williams | CHIEF MEDICAL OFFICER | -9.95K | $4.67 | -$303.87K | SELL | -2.62% | 370.19K | May 03 | View |
| May 01, 2024 | Michael Raab | PRESIDENT & CEO | 0.00 | $3.70 | -$162.36K | SELL-OPTIONS | 0.00% | 1.31M | Apr 29 | View |
| Apr 17, 2024 | Michael Raab | PRESIDENT & CEO | -7.50K | $7.06 | -$52.92K | SELL | -0.57% | 1.31M | Apr 15 | View |
| Apr 02, 2024 | Michael Raab | PRESIDENT & CEO | -1.52K | $7.31 | -$11.10K | SELL | -0.11% | 1.32M | Apr 01 | View |
| Mar 22, 2024 | Elizabeth Grammer | SEE REMARKS | -86.00K | $7.73 | -$664.98K | SELL | -21.55% | 312.99K | Mar 20 | View |
| Feb 28, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -5.18K | $9.20 | -$47.68K | SELL | -0.93% | 554.92K | Feb 26 | View |
| Feb 22, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -7.31K | $8.75 | -$63.94K | SELL | -2.75% | 258.71K | Feb 20 | View |
| Feb 22, 2024 | Justin Renz | CHIEF FINANCIAL OFFICER | -5.34K | $8.75 | -$46.71K | SELL | -1.72% | 304.83K | Feb 20 | View |
| Feb 22, 2024 | Michael Raab | PRESIDENT & CEO | -22.92K | $8.75 | -$200.44K | SELL | -1.71% | 1.32M | Feb 20 | View |
| Feb 22, 2024 | Robert Blanks | SEE REMARKS | -5.02K | $8.75 | -$43.88K | SELL | -1.34% | 368.19K | Feb 20 | View |
| Feb 22, 2024 | Elizabeth Grammer | SEE REMARKS | -4.43K | $8.75 | -$38.76K | SELL | -1.10% | 398.99K | Feb 20 | View |
| Feb 22, 2024 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -6.93K | $8.75 | -$60.59K | SELL | -1.51% | 452.80K | Feb 20 | View |
| Feb 22, 2024 | Robert Ora Felsch | SEE REMARKS | -2.35K | $8.75 | -$20.57K | SELL | -1.26% | 184.83K | Feb 20 | View |
| Feb 22, 2024 | Laura A Williams | CHIEF MEDICAL OFFICER | -4.80K | $8.75 | -$42.01K | SELL | -1.25% | 380.14K | Feb 20 | View |
| Feb 09, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -15.34K | $9.18 | -$140.85K | SELL | -3.22% | 461.59K | Feb 08 | View |
| Jan 10, 2024 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -30.00K | $6.64 | -$199.20K | SELL | -7.61% | 364.19K | Jan 08 | View |
| Dec 28, 2023 | Justin Renz | CHIEF FINANCIAL OFFICER | -150.00K | $3.67 | -$1.36M | SELL | -45.12% | 182.43K | Dec 26 | View |
| Dec 20, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -5.67K | $6.07 | -$34.45K | SELL | -1.42% | 394.19K | Dec 18 | View |
| Dec 15, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -7.00K | $5.55 | -$38.85K | SELL | -1.72% | 399.86K | Dec 14 | View |
| Dec 13, 2023 | Elizabeth Grammer | SEE REMARKS | -50.00K | $5.08 | -$253.93K | SELL | -15.35% | 275.68K | Dec 11 | View |
| Dec 08, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -20.00K | $5.27 | -$105.48K | SELL | -4.69% | 406.86K | Dec 08 | View |
| Dec 06, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -10.27K | $5.00 | -$51.36K | SELL | -2.35% | 426.86K | Dec 05 | View |
| Dec 01, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -3.00K | $4.50 | -$13.50K | SELL | -0.68% | 437.13K | Nov 30 | View |
| Nov 22, 2023 | Laura A Williams | CHIEF MEDICAL OFFICER | -2.58K | $4.36 | -$11.26K | SELL | -0.96% | 266.19K | Nov 20 | View |
| Nov 22, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -3.77K | $4.36 | -$16.43K | SELL | -1.94% | 190.88K | Nov 20 | View |
| Nov 22, 2023 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -4.71K | $4.36 | -$20.56K | SELL | -1.34% | 346.97K | Nov 20 | View |
| Nov 22, 2023 | Justin Renz | CHIEF FINANCIAL OFFICER | -2.87K | $4.36 | -$12.53K | SELL | -0.86% | 332.43K | Nov 20 | View |
| Nov 22, 2023 | Michael Raab | PRESIDENT & CEO | -11.37K | $4.36 | -$49.59K | SELL | -1.29% | 868.87K | Nov 20 | View |
| Nov 22, 2023 | Elizabeth Grammer | SEE REMARKS | -2.38K | $4.36 | -$10.40K | SELL | -0.73% | 325.68K | Nov 20 | View |
| Nov 22, 2023 | Robert Ora Felsch | SEE REMARKS | -1.04K | $4.36 | -$4.55K | SELL | -0.88% | 117.07K | Nov 20 | View |
| Nov 22, 2023 | Robert Blanks | SEE REMARKS | -2.83K | $4.36 | -$12.37K | SELL | -1.08% | 260.45K | Nov 20 | View |
| Nov 17, 2023 | Laura A Williams | CHIEF MEDICAL OFFICER | -25.00K | $4.00 | -$100.00K | SELL | -8.57% | 266.84K | Nov 15 | View |
| Oct 12, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -1.64K | $4.00 | -$6.58K | SELL | -0.37% | 442.97K | Oct 10 | View |
| Sep 12, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -2.90K | $4.55 | -$13.18K | SELL | -0.65% | 444.61K | Sep 08 | View |
| Aug 23, 2023 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -4.73K | $3.55 | -$16.81K | SELL | -1.34% | 348.69K | Aug 21 | View |
| Aug 23, 2023 | Laura A Williams | CHIEF MEDICAL OFFICER | -2.59K | $3.55 | -$9.20K | SELL | -0.88% | 291.84K | Aug 21 | View |
| Aug 23, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -3.78K | $3.55 | -$13.44K | SELL | -1.96% | 188.82K | Aug 21 | View |
| Aug 23, 2023 | Justin Renz | CHIEF FINANCIAL OFFICER | -2.88K | $3.55 | -$10.24K | SELL | -0.86% | 333.85K | Aug 21 | View |
| Aug 23, 2023 | Michael Raab | PRESIDENT & CEO | -11.42K | $3.55 | -$40.56K | SELL | -1.28% | 877.24K | Aug 21 | View |
| Aug 23, 2023 | Elizabeth Grammer | SEE REMARKS | -2.39K | $3.55 | -$8.50K | SELL | -0.72% | 328.06K | Aug 21 | View |
| Aug 23, 2023 | Robert Ora Felsch | SEE REMARKS | -1.05K | $3.55 | -$3.72K | SELL | -0.90% | 115.11K | Aug 21 | View |
| Aug 23, 2023 | Robert Blanks | SEE REMARKS | -2.85K | $3.55 | -$10.11K | SELL | -1.07% | 263.29K | Aug 21 | View |
| Jun 29, 2023 | Laura A Williams | CHIEF MEDICAL OFFICER | -25.00K | $3.35 | -$83.63K | SELL | -7.83% | 294.43K | Jun 27 | View |
| Jun 27, 2023 | Robert Blanks | SEE REMARKS | 0.00 | $3.53 | -$7.04K | SELL-OPTIONS | 0.00% | 266.13K | Jun 23 | View |
| May 25, 2023 | Robert Ora Felsch | SEE REMARKS | -1.05K | $3.65 | -$3.82K | SELL | -0.89% | 116.16K | May 23 | View |
| May 25, 2023 | Michael Raab | PRESIDENT & CEO | -11.36K | $3.65 | -$41.49K | SELL | -1.26% | 888.65K | May 23 | View |
| May 25, 2023 | Elizabeth Grammer | SEE REMARKS | -2.38K | $3.65 | -$8.71K | SELL | -0.72% | 330.45K | May 23 | View |
| May 25, 2023 | Robert Blanks | SEE REMARKS | -2.83K | $3.65 | -$10.36K | SELL | -1.05% | 266.13K | May 23 | View |
| May 25, 2023 | Justin Renz | CHIEF FINANCIAL OFFICER | -2.87K | $3.65 | -$10.50K | SELL | -0.85% | 336.73K | May 23 | View |
| May 25, 2023 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -4.71K | $3.65 | -$17.21K | SELL | -1.32% | 353.42K | May 23 | View |
| May 25, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -3.77K | $3.65 | -$13.77K | SELL | -1.95% | 189.75K | May 23 | View |
| May 25, 2023 | Laura A Williams | CHIEF MEDICAL OFFICER | -2.58K | $3.65 | -$9.44K | SELL | -0.80% | 319.43K | May 23 | View |
| Mar 31, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -3.00K | $4.63 | -$13.89K | SELL | -1.55% | 190.69K | Mar 29 | View |
| Mar 02, 2023 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -5.59K | $3.00 | -$16.76K | SELL | -1.55% | 355.13K | Feb 21 | View |
| Feb 24, 2023 | Laura A Williams | CHIEF MEDICAL OFFICER | -3.19K | $3.00 | -$9.56K | SELL | -0.99% | 319.01K | Feb 21 | View |
| Feb 24, 2023 | Robert Blanks | SEE REMARKS | -3.39K | $3.00 | -$10.19K | SELL | -1.25% | 268.97K | Feb 21 | View |
| Feb 24, 2023 | Elizabeth Grammer | SEE REMARKS | -2.91K | $3.00 | -$8.74K | SELL | -0.87% | 332.93K | Feb 21 | View |
| Feb 24, 2023 | Michael Raab | PRESIDENT & CEO | -13.45K | $3.00 | -$40.36K | SELL | -1.48% | 897.01K | Feb 21 | View |
| Feb 24, 2023 | Robert Ora Felsch | SEE REMARKS | -3.21K | $3.00 | -$9.65K | SELL | -2.74% | 114.20K | Feb 21 | View |
| Feb 24, 2023 | Justin Renz | CHIEF FINANCIAL OFFICER | -3.44K | $3.00 | -$10.32K | SELL | -1.01% | 336.61K | Feb 21 | View |
| Feb 24, 2023 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -4.51K | $3.00 | -$13.53K | SELL | -2.31% | 190.69K | Feb 21 | View |
| Nov 23, 2022 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -1.95K | $1.95 | -$3.80K | SELL | -1.16% | 166.48K | Nov 22 | View |
| Nov 23, 2022 | Elizabeth Grammer | SEE REMARKS | -1.24K | $1.95 | -$2.42K | SELL | -0.48% | 257.84K | Nov 22 | View |
| Nov 23, 2022 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -3.46K | $1.95 | -$6.74K | SELL | -1.21% | 282.72K | Nov 22 | View |
| Nov 23, 2022 | Michael Raab | PRESIDENT & CEO | -6.22K | $1.95 | -$12.12K | SELL | -0.93% | 660.46K | Nov 22 | View |
| Nov 23, 2022 | Justin Renz | CHIEF FINANCIAL OFFICER | -1.50K | $1.95 | -$2.93K | SELL | -0.57% | 262.05K | Nov 22 | View |
| Nov 23, 2022 | Laura A Williams | CHIEF MEDICAL OFFICER | -1.24K | $1.95 | -$2.42K | SELL | -0.51% | 244.20K | Nov 22 | View |
| Nov 23, 2022 | Robert Blanks | SEE REMARKS | -1.46K | $1.95 | -$2.85K | SELL | -0.75% | 194.36K | Nov 22 | View |
| Nov 17, 2022 | David Mott | DIRECTOR | 567.00K | $1.76 | $1.00M | BUY | 94.54% | 1.17M | Nov 17 | View |
| Oct 07, 2022 | Robert Blanks | SEE REMARKS | -100.00K | $1.50 | -$150.00K | SELL | -33.80% | 195.83K | Oct 05 | View |
| Sep 01, 2022 | Robert Ora Felsch | SEE REMARKS | 3.00K | $0.62 | $1.86K | BUY | 3.39% | 91.42K | Aug 31 | View |
| Sep 01, 2022 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | 0.00 | $0.77 | -$903.90 | p / s | 0.00% | 391.83K | Aug 31 - Sep 01 | View |
| Sep 01, 2022 | Justin Renz | CHIEF FINANCIAL OFFICER | 3.00K | $0.62 | $1.86K | BUY | 1.15% | 263.55K | Aug 31 | View |
| Sep 01, 2022 | Laura A Williams | CHIEF MEDICAL OFFICER | 3.00K | $0.62 | $1.86K | BUY | 1.24% | 245.44K | Aug 31 | View |
| Sep 01, 2022 | Michael Raab | PRESIDENT & CEO | 3.00K | $0.62 | $1.86K | BUY | 0.45% | 666.68K | Aug 31 | View |
| Sep 01, 2022 | Elizabeth Grammer | SEE REMARKS | 3.00K | $0.62 | $1.86K | BUY | 1.17% | 259.08K | Aug 31 | View |
| Aug 29, 2022 | Robert Blanks | SEE REMARKS | -21.84K | $1.04 | -$22.71K | SELL | -6.88% | 295.83K | Aug 26 | View |
| Aug 24, 2022 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -3.42K | $0.98 | -$3.36K | SELL | -1.18% | 286.17K | Aug 22 | View |
| Aug 24, 2022 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -1.96K | $0.98 | -$1.92K | SELL | -1.16% | 166.96K | Aug 22 | View |
| Aug 24, 2022 | Robert Blanks | SEE REMARKS | -1.46K | $0.98 | -$1.43K | SELL | -0.46% | 317.67K | Aug 22 | View |
| Aug 24, 2022 | Michael Raab | PRESIDENT & CEO | -6.15K | $0.98 | -$6.05K | SELL | -0.92% | 663.68K | Aug 22 | View |
| Aug 24, 2022 | Elizabeth Grammer | SEE REMARKS | -1.24K | $0.98 | -$1.22K | SELL | -0.48% | 256.08K | Aug 22 | View |
| Aug 24, 2022 | Laura A Williams | CHIEF MEDICAL OFFICER | -1.28K | $0.98 | -$1.26K | SELL | -0.52% | 242.44K | Aug 22 | View |
| Aug 24, 2022 | Justin Renz | CHIEF FINANCIAL OFFICER | -1.50K | $0.98 | -$1.47K | SELL | -0.57% | 260.55K | Aug 22 | View |
| Jul 28, 2022 | Robert Blanks | SEE REMARKS | -5.19K | $0.67 | -$3.48K | SELL | -1.60% | 319.13K | Jul 26 | View |
| Jun 08, 2022 | Justin Renz | CHIEF FINANCIAL OFFICER | -73.31K | $0.65 | -$47.70K | SELL | -21.86% | 262.05K | Jun 06 | View |
| Jun 08, 2022 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -43.92K | $0.65 | -$28.57K | SELL | -13.17% | 289.59K | Jun 06 | View |
| Jun 08, 2022 | Robert Blanks | SEE REMARKS | -73.31K | $0.65 | -$47.70K | SELL | -18.44% | 324.31K | Jun 06 | View |
| Jun 08, 2022 | Elizabeth Grammer | SEE REMARKS | -60.82K | $0.65 | -$39.57K | SELL | -19.12% | 257.32K | Jun 06 | View |
| Jun 08, 2022 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -61.64K | $0.65 | -$40.10K | SELL | -26.91% | 167.46K | Jun 06 | View |
| Jun 08, 2022 | Michael Raab | PRESIDENT & CEO | -103.62K | $0.65 | -$67.42K | SELL | -13.40% | 669.83K | Jun 06 | View |
| May 23, 2022 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -2.01K | $0.67 | -$1.35K | SELL | -1.08% | 185.09K | May 20 | View |
| May 23, 2022 | Justin Renz | CHIEF FINANCIAL OFFICER | -1.53K | $0.67 | -$1.03K | SELL | -0.45% | 335.36K | May 20 | View |
| May 23, 2022 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -3.42K | $0.67 | -$2.30K | SELL | -1.02% | 333.51K | May 20 | View |
| May 23, 2022 | Robert Blanks | SEE REMARKS | -1.49K | $0.67 | -$999.71 | SELL | -0.37% | 397.63K | May 20 | View |
| May 23, 2022 | Michael Raab | PRESIDENT & CEO | -6.12K | $0.67 | -$4.11K | SELL | -0.79% | 773.45K | May 20 | View |
| May 23, 2022 | Elizabeth Grammer | SEE REMARKS | -1.26K | $0.67 | -$847.98 | SELL | -0.40% | 318.14K | May 20 | View |
| Feb 25, 2022 | Justin Renz | CHIEF FINANCIAL OFFICER | -1.80K | $0.67 | -$1.21K | SELL | -0.54% | 333.89K | Feb 22 | View |
| Feb 25, 2022 | Robert Blanks | SEE REMARKS | -1.75K | $0.67 | -$1.17K | SELL | -0.44% | 399.12K | Feb 22 | View |
| Feb 25, 2022 | Michael Raab | PRESIDENT & CEO | -6.23K | $0.67 | -$4.17K | SELL | -0.80% | 776.57K | Feb 22 | View |
| Feb 25, 2022 | Elizabeth Grammer | SEE REMARKS | -1.53K | $0.67 | -$1.02K | SELL | -0.48% | 319.40K | Feb 22 | View |
| Feb 25, 2022 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -2.35K | $0.67 | -$1.58K | SELL | -1.27% | 182.62K | Feb 22 | View |
| Feb 25, 2022 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -3.40K | $0.67 | -$2.28K | SELL | -1.01% | 333.94K | Feb 22 | View |
| Dec 27, 2021 | SCOTT SANDELL | 10% OWNER | -2.88M | $1.26 | -$3.64M | SELL | -56.06% | 2.26M | Dec 09 - Dec 15 | View |
| Dec 27, 2021 | FOREST BASKETT | 10% OWNER | -2.88M | $1.26 | -$3.64M | SELL | -56.06% | 2.26M | Dec 09 - Dec 15 | View |
| Nov 24, 2021 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -827.00 | $0.99 | -$820.28 | SELL | -0.49% | 168.22K | Nov 22 | View |
| Nov 24, 2021 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -643.00 | $0.99 | -$637.79 | SELL | -0.33% | 197.03K | Nov 22 | View |
| Nov 24, 2021 | Justin Renz | CHIEF FINANCIAL OFFICER | -643.00 | $0.99 | -$637.79 | SELL | -0.22% | 293.69K | Nov 22 | View |
| Nov 24, 2021 | Michael Raab | PRESIDENT & CEO | -2.61K | $0.99 | -$2.59K | SELL | -0.41% | 632.80K | Nov 22 | View |
| Nov 24, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | -5.75K | $0.98 | -$5.63K | SELL | -4.59% | 119.48K | Nov 22 | View |
| Nov 24, 2021 | Robert Blanks | SEE REMARKS | -643.00 | $0.99 | -$637.79 | SELL | -0.18% | 360.87K | Nov 22 | View |
| Nov 24, 2021 | Elizabeth Grammer | SEE REMARKS | -537.00 | $0.99 | -$532.65 | SELL | -0.19% | 278.93K | Nov 22 | View |
| Nov 16, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | -5.00K | $1.13 | -$5.65K | SELL | -3.84% | 125.24K | Nov 15 | View |
| Nov 12, 2021 | Elizabeth Grammer | SEE REMARKS | -77.43K | $1.13 | -$87.11K | SELL | -21.70% | 279.47K | Nov 12 | View |
| Nov 10, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | -2.17K | $1.18 | -$2.56K | SELL | -1.64% | 130.24K | Nov 08 | View |
| Aug 24, 2021 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -807.00 | $1.32 | -$1.07K | SELL | -0.77% | 104.17K | Aug 20 | View |
| Aug 24, 2021 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -630.00 | $1.32 | -$831.60 | SELL | -1.39% | 44.67K | Aug 20 | View |
| Aug 24, 2021 | Justin Renz | CHIEF FINANCIAL OFFICER | -631.00 | $1.32 | -$832.92 | SELL | -1.55% | 40.05K | Aug 20 | View |
| Aug 24, 2021 | Michael Raab | PRESIDENT & CEO | -2.57K | $1.32 | -$3.40K | SELL | -0.77% | 330.73K | Aug 20 | View |
| Aug 24, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | -741.00 | $1.32 | -$978.12 | SELL | -0.58% | 127.70K | Aug 20 | View |
| Aug 24, 2021 | Elizabeth Grammer | SEE REMARKS | -526.00 | $1.32 | -$694.32 | SELL | -0.50% | 105.36K | Aug 20 | View |
| Aug 24, 2021 | Robert Blanks | SEE REMARKS | -631.00 | $1.32 | -$832.92 | SELL | -0.59% | 106.32K | Aug 20 | View |
| Jun 17, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | 0.00 | $3.91 | -$50.61K | SELL-OPTIONS | 0.00% | 124.05K | Jun 15 | View |
| Jun 02, 2021 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -3.06K | $7.22 | -$22.10K | SELL | -1.62% | 186.19K | May 28 | View |
| May 21, 2021 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -769.00 | $7.09 | -$5.45K | SELL | -0.71% | 107.40K | May 20 | View |
| May 21, 2021 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -611.00 | $7.09 | -$4.33K | SELL | -1.33% | 45.30K | May 20 | View |
| May 21, 2021 | Justin Renz | CHIEF FINANCIAL OFFICER | -612.00 | $7.09 | -$4.34K | SELL | -1.48% | 40.68K | May 20 | View |
| May 21, 2021 | Michael Raab | PRESIDENT & CEO | -2.53K | $7.09 | -$17.96K | SELL | -1.16% | 215.75K | May 20 | View |
| May 21, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | -721.00 | $7.09 | -$5.11K | SELL | -0.58% | 124.05K | May 20 | View |
| May 21, 2021 | Elizabeth Grammer | SEE REMARKS | -508.00 | $7.09 | -$3.60K | SELL | -0.48% | 105.88K | May 20 | View |
| May 21, 2021 | Robert Blanks | SEE REMARKS | -612.00 | $7.09 | -$4.34K | SELL | -0.57% | 106.95K | May 20 | View |
| Apr 08, 2021 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -5.00K | $8.00 | -$40.00K | SELL | -2.06% | 237.64K | Apr 06 | View |
| Apr 08, 2021 | Robert Blanks | SEE REMARKS | -5.16K | $8.00 | -$41.30K | SELL | -4.58% | 107.57K | Apr 06 | View |
| Feb 24, 2021 | Robert Blanks | SEE REMARKS | -593.00 | $6.88 | -$4.08K | SELL | -0.52% | 112.73K | Feb 22 | View |
| Feb 24, 2021 | Jeffrey W Jacobs | CHIEF SCIENTIFIC OFFICER | -702.00 | $6.88 | -$4.83K | SELL | -0.56% | 124.77K | Feb 22 | View |
| Feb 24, 2021 | Susan Rodriguez | CHIEF COMMERCIAL OFFICER | -611.00 | $6.88 | -$4.21K | SELL | -1.31% | 45.91K | Feb 22 | View |
| Feb 24, 2021 | Michael Raab | PRESIDENT & CEO | -2.53K | $6.88 | -$17.44K | SELL | -1.15% | 218.29K | Feb 22 | View |
| Feb 24, 2021 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -805.00 | $6.88 | -$5.54K | SELL | -0.74% | 107.56K | Feb 22 | View |
| Feb 24, 2021 | Justin Renz | CHIEF FINANCIAL OFFICER | -608.00 | $6.88 | -$4.18K | SELL | -1.45% | 41.29K | Feb 22 | View |
| Feb 24, 2021 | Elizabeth Grammer | SEE REMARKS | -504.00 | $6.88 | -$3.47K | SELL | -0.47% | 106.39K | Feb 22 | View |
| Dec 22, 2020 | Jeffrey W Jacobs | — | -3.95K | $6.88 | -$27.15K | SELL | -4.08% | 92.86K | Dec 21 | View |
| Dec 15, 2020 | Elizabeth Grammer | — | 0.00 | $4.81 | -$209.16K | OPTION EXERCISE | 0.00% | 75.09K | Dec 11 - Dec 14 | View |
| Dec 10, 2020 | David Mott | — | 170.00K | $5.89 | $1.00M | PURCHASE | 68.75% | 417.28K | Dec 10 | View |
| Sep 17, 2020 | Susan Rodriguez | — | -6.09K | $6.11 | -$37.16K | SELL | -30.44% | 13.91K | Sep 16 | View |
| Sep 17, 2020 | David Rosenbaum | — | -38.13K | $5.52 | -$210.43K | SELL | -27.75% | 99.25K | Sep 15 | View |
| Sep 17, 2020 | Robert Blanks | — | -34.69K | $5.45 | -$189.18K | SELL | -30.06% | 80.71K | Sep 15 | View |
| Sep 17, 2020 | Justin Renz | — | -3.71K | $5.49 | -$20.37K | SELL | -28.57% | 9.29K | Sep 15 | View |
| Sep 17, 2020 | Michael Raab | — | -106.34K | $5.61 | -$596.28K | SELL | -50.15% | 105.72K | Sep 15 | View |
| Sep 17, 2020 | Elizabeth Grammer | — | -28.81K | $5.37 | -$154.57K | SELL | -27.73% | 75.09K | Sep 15 | View |
| Sep 17, 2020 | Jeffrey W Jacobs | — | -50.80K | $5.63 | -$286.09K | SELL | -34.42% | 96.81K | Sep 15 - Sep 16 | View |
| Sep 03, 2020 | Robert Blanks | — | -2.05K | $5.58 | -$11.43K | SELL | -1.74% | 115.39K | Sep 01 | View |
| Jul 06, 2020 | Michael Raab | — | -23.13K | $7.01 | -$162.13K | SELL | -9.05% | 232.42K | Jul 02 | View |
| Jun 26, 2020 | David Mott | — | 140.97K | $6.85 | $965.90K | PURCHASE | 132.60% | 247.28K | Jun 24 - Jun 25 | View |
| Jun 24, 2020 | David Mott | — | 4.67K | $6.75 | $31.52K | PURCHASE | 4.60% | 106.31K | Jun 22 | View |
| Jun 17, 2020 | SCOTT SANDELL | — | -43.00 | $6.37 | -$273.91 | SELL | -47.78% | 47.00 | Jun 15 | View |
| Jun 17, 2020 | FOREST BASKETT | — | -43.00 | $6.37 | -$273.91 | SELL | -0.00% | 2.94M | Jun 15 | View |
| Jun 12, 2020 | SCOTT SANDELL | — | -2.49M | $6.37 | -$573.15K | ACQUISITION OR DISPOSITION | -100.00% | 43.00 | Jun 10 - Jun 12 | View |
| Jun 12, 2020 | FOREST BASKETT | — | -2.50M | $6.37 | -$719.02K | ACQUISITION OR DISPOSITION | -100.00% | 43.00 | Jun 10 - Jun 12 | View |
| Jun 02, 2020 | Michael Raab | — | -23.13K | $7.33 | -$169.63K | SELL | -8.34% | 254.31K | Jun 01 | View |
| May 05, 2020 | Michael Raab | — | -20.43K | $7.01 | -$143.22K | SELL | -6.86% | 277.44K | May 04 - May 05 | View |
| Apr 28, 2020 | Elizabeth Grammer | — | -17.82K | $7.47 | -$133.17K | SELL | -14.67% | 103.67K | Apr 27 | View |
| Apr 17, 2020 | Michael Raab | — | -20.43K | $7.02 | -$143.33K | SELL | -18.36% | 90.81K | Apr 15 - Apr 17 | View |
| Mar 04, 2020 | Michael Raab | — | -20.43K | $4.04 | -$209.13K | OPTION EXERCISE | -15.51% | 111.24K | Mar 02 | View |
| Feb 07, 2020 | Michael Raab | — | 0.00 | $4.20 | -$155.93K | OPTION EXERCISE | 0.00% | 207.83K | Feb 05 | View |
| Jan 02, 2020 | Elizabeth Grammer | — | 66.00 | $7.51 | $495.92 | PURCHASE | 0.05% | 120.28K | Dec 30 | View |
| Dec 05, 2019 | Elizabeth Grammer | EVP, GENERAL COUNSEL | 0.00 | $5.71 | -$22.90K | SELL-OPTIONS | 0.00% | 120.22K | Dec 03 | View |
| Nov 21, 2019 | Elizabeth Grammer | EVP, GENERAL COUNSEL | 0.00 | $5.21 | -$17.90K | SELL-OPTIONS | 0.00% | 120.22K | Nov 19 | View |
| Oct 08, 2019 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | 0.00 | $2.55 | -$80.39K | SELL-OPTIONS | 0.00% | 141.42K | Oct 07 | View |
| Aug 23, 2019 | Elizabeth Grammer | EVP, GENERAL COUNSEL | -5.00K | $3.50 | -$17.50K | SELL | -4.07% | 117.89K | Aug 21 - Aug 22 | View |
| Aug 20, 2019 | Elizabeth Grammer | EVP, GENERAL COUNSEL | -5.87K | $0.00 | $0.00 | SELL | -4.56% | 122.89K | Aug 19 | View |
| Jun 06, 2019 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -2.86K | $2.54 | -$7.26K | SELL | -1.19% | 237.76K | Jun 04 | View |
| Jun 06, 2019 | Michael Raab | PRESIDENT & CEO | -10.05K | $2.54 | -$25.55K | SELL | -3.79% | 255.35K | Jun 04 | View |
| Jun 06, 2019 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | -3.36K | $2.55 | -$8.55K | SELL | -2.36% | 139.09K | Jun 04 | View |
| Jun 06, 2019 | Elizabeth Grammer | SVP, GENERAL COUNSEL | -4.52K | $2.54 | -$6.40K | SELL | -3.44% | 126.76K | May 31 - Jun 04 | View |
| Jan 04, 2019 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -6.39K | $1.70 | -$10.87K | SELL | -6.26% | 95.62K | Jan 02 | View |
| Jan 04, 2019 | Michael Raab | PRESIDENT & CEO | -19.64K | $1.70 | -$33.42K | SELL | -6.96% | 262.41K | Jan 02 | View |
| Jan 04, 2019 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | -6.56K | $1.70 | -$11.15K | SELL | -4.48% | 139.93K | Jan 02 | View |
| Jan 04, 2019 | Elizabeth Grammer | EVP, GENERAL COUNSEL | -4.92K | $1.70 | -$8.37K | SELL | -3.64% | 130.28K | Jan 02 | View |
| Nov 15, 2018 | Elizabeth Grammer | EVP, GENERAL COUNSEL | -8.54K | $2.84 | -$18.57K | SELL | -5.98% | 134.20K | Sep 21 - Nov 13 | View |
| Nov 15, 2018 | Michael Raab | PRESIDENT & CEO | -6.54K | $2.84 | -$18.57K | SELL | -2.18% | 293.50K | Nov 13 | View |
| Nov 15, 2018 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | -6.54K | $2.84 | -$18.57K | SELL | -4.27% | 146.49K | Nov 13 | View |
| Nov 15, 2018 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -5.57K | $2.84 | -$15.82K | SELL | -2.24% | 243.20K | Nov 13 | View |
| Nov 13, 2018 | SCOTT SANDELL | 10% OWNER | -592.00 | $2.98 | -$1.77K | SELL | -0.02% | 3.08M | Nov 12 | View |
| Jun 01, 2018 | Gordon Ringold | DIRECTOR | 10.00K | $4.00 | $40.00K | BUY | 40.00% | 35.00K | May 30 | View |
| Oct 26, 2017 | Reginald Seeto | CHIEF OPERATING OFFICER | -10.01K | $5.20 | -$52.04K | SELL | -6.26% | 149.88K | Oct 24 | View |
| Aug 31, 2017 | FOREST BASKETT | 10% OWNER | -485.00 | $4.95 | -$2.40K | SELL | -0.02% | 2.67M | Aug 30 | View |
| Apr 21, 2017 | David Rosenbaum | CHIEF DEVELOPMENT OFFICER | -2.05K | $11.98 | -$24.58K | SELL | -1.71% | 117.72K | Apr 18 | View |
| Mar 14, 2017 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -1.00K | $13.48 | -$13.48K | SELL | -1.25% | 78.87K | Mar 10 | View |
| Mar 03, 2017 | Jeremy S Caldwell | EVP, CHIEF SCIENTIFIC OFFICER | -1.03K | $14.14 | -$14.51K | SELL | -5.40% | 17.98K | Mar 03 | View |
| Mar 03, 2017 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $7.12 | -$39.48K | SELL-OPTIONS | 0.00% | 68.45K | Mar 01 | View |
| Feb 03, 2017 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $6.27 | -$34.38K | SELL-OPTIONS | 0.00% | 67.51K | Feb 01 | View |
| Jan 23, 2017 | Paul Korner | EVP, CHIEF MEDICAL OFFICER | -6.13K | $12.95 | -$79.38K | SELL | -10.09% | 54.62K | Jan 05 | View |
| Dec 20, 2016 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -900.00 | $14.48 | -$13.04K | SELL | -1.14% | 78.23K | Dec 16 | View |
| Nov 15, 2016 | Jeremy S Caldwell | EVP, CHIEF SCIENTIFIC OFFICER | -2.16K | $15.13 | -$32.65K | SELL | -100.00% | 0.00 | Nov 11 | View |
| Oct 13, 2016 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $7.77 | -$86.76K | SELL-OPTIONS | 0.00% | 49.52K | Oct 11 | View |
| Sep 26, 2016 | Elizabeth Grammer | SVP, GENERAL COUNSEL | 0.00 | $7.13 | -$48.75K | SELL-OPTIONS | 0.00% | 0.00 | Sep 22 - Sep 23 | View |
| Sep 21, 2016 | Elizabeth Grammer | SVP, GENERAL COUNSEL | -1.86K | $6.14 | -$71.48K | SELL | -100.00% | 0.00 | Sep 19 | View |
| Jul 20, 2016 | Harry Weller | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.11% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | Ravi Viswanathan | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.18% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | Peter Sonsini | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.18% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | SCOTT SANDELL | 10% OWNER | 2.29M | $8.73 | $20.00M | BUY | 610.66% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | Jon Sakoda | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.18% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | DAVID MOTT | DIRECTOR | 1.53M | $8.73 | $13.33M | BUY | 132.51% | 2.68M | Jul 18 | View |
| Jul 20, 2016 | JOSHUA MAKOWER | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.18% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | KITTU KRISHNA KOLLURI | 10% OWNER | 2.29M | $8.73 | $20.00M | BUY | 611.62% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | PATRICK KERINS | 10% OWNER | 763.65K | $8.73 | $6.67M | BUY | 9.56% | 8.75M | Jul 18 | View |
| Jul 20, 2016 | Anthony Florence Jr | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.18% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | FOREST BASKETT | 10% OWNER | 2.29M | $8.73 | $20.00M | BUY | 610.83% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | PETER BARRIS | 10% OWNER | 2.29M | $8.73 | $20.00M | BUY | 611.40% | 2.67M | Jul 18 | View |
| Jul 20, 2016 | JAMES BARRETT | 10% OWNER | 763.65K | $8.73 | $6.67M | BUY | 9.56% | 8.75M | Jul 18 | View |
| Jul 20, 2016 | Partnership Limited Associates Enterprise NewPartnership Limited Partners NEANEA GP LLC | 10% OWNER | 763.65K | $8.73 | $6.67M | BUY | 9.56% | 8.75M | Jul 18 | View |
| Jul 20, 2016 | NEA GP LLC | 10% OWNER | 1.53M | $8.73 | $13.33M | BUY | 134.18% | 2.67M | Jul 18 | View |
| Mar 21, 2016 | Gordon Ringold | DIRECTOR | 15.00K | $7.77 | $116.54K | BUY | 150.00% | 25.00K | Mar 21 | View |
| Mar 07, 2016 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -1.13K | $10.74 | -$12.11K | SELL | -4.55% | 23.68K | Mar 03 | View |
| Feb 18, 2016 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | 0.00 | $5.40 | -$48.57K | SELL-OPTIONS | 0.00% | 1.28K | Feb 16 | View |
| Jan 15, 2016 | Jon Sakoda | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | Harry Weller | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | Ravi Viswanathan | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | Peter Sonsini | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | SCOTT SANDELL | 10% OWNER | 1.50M | $10.00 | $15.00M | BUY | 372.71% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | DAVID MOTT | DIRECTOR | 1.00M | $10.00 | $10.00M | BUY | 110.17% | 1.91M | Jan 13 | View |
| Jan 14, 2016 | JOSHUA MAKOWER | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | KITTU KRISHNA KOLLURI | 10% OWNER | 1.50M | $10.00 | $15.00M | BUY | 373.26% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | PATRICK KERINS | 10% OWNER | 500.00K | $10.00 | $5.00M | BUY | 6.68% | 7.99M | Jan 13 | View |
| Jan 14, 2016 | Anthony Florence Jr | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | FOREST BASKETT | 10% OWNER | 1.50M | $10.00 | $15.00M | BUY | 372.81% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | PETER BARRIS | 10% OWNER | 1.50M | $10.00 | $15.00M | BUY | 373.13% | 1.90M | Jan 13 | View |
| Jan 14, 2016 | JAMES BARRETT | 10% OWNER | 500.00K | $10.00 | $5.00M | BUY | 6.68% | 7.99M | Jan 13 | View |
| Jan 14, 2016 | Partnership Limited Associates Enterprise NewPartnership Limited Partners NEANEA GP LLC | 10% OWNER | 500.00K | $10.00 | $5.00M | BUY | 6.68% | 7.99M | Jan 13 | View |
| Jan 14, 2016 | NEA GP LLC | 10% OWNER | 1.00M | $10.00 | $10.00M | BUY | 110.88% | 1.90M | Jan 13 | View |
| Dec 21, 2015 | William Bertrand Jr. | DIRECTOR | 5.00K | $20.00 | $100.00K | BUY | ∞ | 5.00K | Dec 17 | View |
| Dec 17, 2015 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $10.27 | -$38.92K | SELL-OPTIONS | 0.00% | 47.42K | Dec 15 | View |
| Dec 01, 2015 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $10.27 | -$38.92K | SELL-OPTIONS | 0.00% | 47.42K | Nov 27 | View |
| Oct 13, 2015 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $10.21 | -$38.68K | SELL-OPTIONS | 0.00% | 47.42K | Oct 08 | View |
| Sep 23, 2015 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -1.40K | $22.05 | -$30.87K | SELL | -1.39% | 99.53K | Sep 21 - Sep 22 | View |
| Sep 17, 2015 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -2.54K | $22.01 | -$55.90K | SELL | -2.45% | 100.93K | Sep 15 | View |
| Sep 11, 2015 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $10.57 | -$40.10K | SELL-OPTIONS | 0.00% | 47.42K | Sep 10 | View |
| Sep 10, 2015 | Michael Raab | PRESIDENT & CEO | -9.79K | $20.29 | -$198.54K | SELL | -11.98% | 71.90K | Sep 08 | View |
| Sep 03, 2015 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -2.54K | $18.78 | -$47.64K | SELL | -2.39% | 103.47K | Sep 01 - Sep 03 | View |
| Sep 03, 2015 | Jeremy S Caldwell | EVP, CHIEF SCIENTIFIC OFFICER | -643.00 | $18.32 | -$11.78K | SELL | -100.00% | 0.00 | Sep 01 | View |
| Sep 03, 2015 | Elizabeth Grammer | VP, GENERAL COUNSEL | -893.00 | $18.32 | -$16.36K | SELL | -100.00% | 0.00 | Sep 01 | View |
| Aug 27, 2015 | Michael Raab | PRESIDENT & CEO | -1.10K | $20.00 | -$22.08K | SELL | -1.36% | 80.17K | Aug 18 | View |
| Aug 11, 2015 | Jeffrey W Jacobs | SVP, TECHNICAL OPERATIONS | 0.00 | $9.80 | -$37.06K | SELL-OPTIONS | 0.00% | 46.67K | Aug 06 | View |
| Aug 04, 2015 | Michael Raab | PRESIDENT & CEO | -300.00 | $20.00 | -$6.00K | SELL | -0.37% | 81.27K | Aug 03 | View |
| Aug 03, 2015 | David Rosenbaum | SVP, DRUG DEVELOPMENT | -2.01K | $19.27 | -$38.76K | SELL | -2.50% | 78.36K | Jul 30 | View |
| Jul 30, 2015 | Michael Raab | PRESIDENT & CEO | -2.11K | $20.00 | -$42.22K | SELL | -2.52% | 81.57K | Jul 28 | View |
| Jul 29, 2015 | Jeffrey W Jacobs | SENIOR VP, TECHNICAL OPS | 5.00K | $10.27 | $51.35K | SELL-OPTIONS | 12.00% | 46.67K | Jul 28 | View |
| Jul 23, 2015 | Elizabeth Grammer | VP, GENERAL COUNSEL | 0.00 | $9.54 | -$42.30K | SELL-OPTIONS | 0.00% | 0.00 | Jul 22 | View |
| Jul 16, 2015 | Elizabeth Grammer | VP, GENERAL COUNSEL | -5.00K | $8.83 | -$168.45K | SELL | -100.00% | 0.00 | Jul 15 | View |
| Jun 12, 2015 | Gordon Ringold | DIRECTOR | 10.00K | $15.19 | $151.88K | BUY | ∞ | 10.00K | Jun 10 | View |
| Jun 09, 2015 | PETER BARRIS | 10% OWNER | 4.67M | $10.70 | $50.00M | BUY | ∞ | 1.40M | Jun 05 | View |
| Jun 09, 2015 | JAMES BARRETT | 10% OWNER | 1.87M | $10.70 | $20.00M | BUY | 33.26% | 7.49M | Jun 05 | View |
| Jun 09, 2015 | FOREST BASKETT | 10% OWNER | 4.67M | $10.70 | $50.00M | BUY | ∞ | 1.40M | Jun 05 | View |
| Jun 09, 2015 | RYAN DRANT | 10% OWNER | 1.87M | $10.70 | $20.00M | BUY | 33.26% | 7.49M | Jun 05 | View |
| Jun 09, 2015 | PATRICK KERINS | 10% OWNER | 1.87M | $10.70 | $20.00M | BUY | 33.26% | 7.49M | Jun 05 | View |
| Jun 09, 2015 | SCOTT SANDELL | 10% OWNER | 4.67M | $10.70 | $50.00M | BUY | ∞ | 1.40M | Jun 05 | View |
| Jun 09, 2015 | KITTU KRISHNA KOLLURI | 10% OWNER | 4.67M | $10.70 | $50.00M | BUY | ∞ | 1.40M | Jun 05 | View |
| Jun 09, 2015 | DAVID MOTT | DIRECTOR | 2.80M | $10.70 | $30.00M | BUY | ∞ | 1.40M | Jun 05 | View |
| Jun 09, 2015 | Partnership Limited Associates Enterprise NewPartnership Limited Partners NEANEA GP LLC | 10% OWNER | 1.87M | $10.70 | $20.00M | BUY | 33.26% | 7.49M | Jun 05 | View |
| Jun 08, 2015 | Peter Schultz | DIRECTOR | 46.73K | $10.70 | $500.00K | BUY | 5.43% | 907.43K | Jun 05 | View |
| May 05, 2015 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | 0.00 | $5.68 | -$93.33K | SELL-OPTIONS | 0.00% | 596.00 | May 04 | View |
| Apr 08, 2015 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | 0.00 | $6.67 | -$94.18K | SELL-OPTIONS | 0.00% | 596.00 | Apr 06 | View |
| Mar 05, 2015 | Mark Kaufmann | CHIEF FINANCIAL OFFICER | 0.00 | $8.07 | -$91.47K | SELL-OPTIONS | 0.00% | 596.00 | Mar 03 | View |
| Mar 04, 2015 | Elizabeth Grammer | VP, GENERAL COUNSEL | -1.74K | $15.81 | -$27.47K | SELL | -25.78% | 5.00K | Mar 02 | View |
| Mar 04, 2015 | Jeffrey Jacobs | VP, CHEMISTRY | -981.00 | $15.81 | -$15.51K | SELL | -2.06% | 46.67K | Mar 02 | View |
| Mar 04, 2015 | George Jue | VP, OPERATIONS | -1.50K | $15.88 | -$23.82K | SELL | -5.05% | 28.19K | Mar 02 | View |
| Feb 06, 2015 | Jeffrey Jacobs | VP, CHEMISTRY | 0.00 | $8.68 | -$135.14K | SELL-OPTIONS | 0.00% | 46.67K | Feb 04 | View |
| Feb 03, 2015 | CMEA Ventures VII LPCMEA VENTURES VII PARALLEL LP | 10% OWNER | -170.00K | $27.37 | -$4.65M | SELL | -67.73% | 80.99K | Jan 30 | View |
| Jan 12, 2015 | CMEA Ventures VII LPCMEA VENTURES VII PARALLEL LP | 10% OWNER | -300.00K | $24.25 | -$7.28M | SELL | -77.87% | 85.24K | Jan 08 | View |
| Dec 29, 2014 | PETER BARRIS | 10% OWNER | -9.42K | $21.28 | -$41.96K | SELL | -0.17% | 5.62M | Dec 23 - Dec 26 | View |
| Dec 29, 2014 | JAMES BARRETT | 10% OWNER | -10.00K | $21.34 | -$54.72K | SELL | -0.18% | 5.62M | Dec 23 - Dec 26 | View |
| Dec 29, 2014 | FOREST BASKETT | 10% OWNER | -9.52K | $21.28 | -$41.96K | SELL | -0.17% | 5.62M | Dec 23 - Dec 26 | View |
| Dec 29, 2014 | KITTU KRISHNA KOLLURI | 10% OWNER | -10.00K | $20.09 | -$5.36K | SELL | -0.18% | 5.62M | Dec 23 - Dec 29 | View |
| Dec 29, 2014 | SCOTT SANDELL | 10% OWNER | -9.41K | $21.28 | -$41.96K | SELL | -0.17% | 5.62M | Dec 23 - Dec 26 | View |
| Jun 26, 2014 | Partnership Limited Associates Enterprise NewPartnership Limited Partners NEANEA GP LLCJAMES BARRETTPETER BARRISFOREST BASKETTRYAN DRANTPATRICK KERINSKITTU KRISHNA KOLLURISCOTT SANDELL | 10% OWNER | 6.62M | $14.00 | $7.15M | BUY | ∞ | 6.62M | Jun 24 | View |
| Jun 26, 2014 | CMEA Ventures VII LPCMEA VENTURES VII PARALLEL LP | 10% OWNER | 4.11M | $14.00 | $4.44M | BUY | ∞ | 102.74K | Jun 24 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
ARDX Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved